Large, mid-size and small pharma companies are invited to attend the 18th Biopharma Medical Affairs Nexus being held October 17-18, 2023, in Philadelphia. The event will focus on networking and the flow of important data in key areas of Medical Affairs, Medical Operations, Medical Excellence, MSL, Medical Communications, Scientific Affairs, Field Medical, Medical Education, Clinical Investigation, Business Intelligence, and Medical Science.
The event is hosted by BioPharma Nexus, a premier company organizing top-notch conferences that develop and strengthen ties between pharmaceutical and biotech companies, along with the service providers. They strive to offer the best-quality healthcare and medication to patients all over the globe. Industries can identify and connect with partners to foster scientific and healthcare collaborations.
The BioPharma Nexus Conference offers a valuable networking platform for different sectors of the pharma and biotech industry. Small and mid-sized companies can leverage the conference floor to gain visibility and expand their connections in the pharma spectrum. Eminent speakers and stalwarts from the biopharma industry will share their critical insights and discuss the latest trends in the industry.
Benefits of attending the conference:
- Expand networking horizons and develop long-term business relations for better growth and expansion opportunities
- Gain insightful knowledge and learn about the latest trends in the biopharma spectrum
- Connect with the industry leaders to stay updated with the latest technological advancements as well as the target audience
- Learn the latest offerings and get innovative ideas and solutions for business operations
- Showcase your product and business ideas on a unified conference platform with high reach and connectivity
The BioPharma Nexus Conference offers a great learning floor to connect companies, service providers and patients for meaningful collaborations.
To know more, please visit https://ibn.fm/22ZJE.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN